Literature DB >> 21947424

Long-term visual outcome and aneurysm obliteration rate for very large and giant ophthalmic segment aneurysms: assessment of surgical treatment.

Amir R Dehdashti1, Andre Le Roux, Susanna Bacigaluppi, M Christopher Wallace.   

Abstract

BACKGROUND: Standard endovascular therapy has shown little success in treatment of very large and giant ophthalmic segment aneurysms. We hypothesize that surgical treatment of these aneurysms yields better results in terms of visual function and aneurysm obliteration.
METHODS: The Toronto Brain Vascular Malformation Study Group database was analyzed to retrieve patients treated surgically for very large (>15 mm) and giant aneurysms of the ophthalmic segment of the carotid artery. Preoperative data and postoperative long-term outcomes with specific consideration for visual function and aneurysm obliteration were evaluated.
RESULTS: Of the 257 patients with ophthalmic and paraophthalmic aneurysms, 38 patients had very large or giant aneurysms. Twenty-one underwent surgical treatment; 19 had direct clipping; 1 had trapping, and 1 underwent trapping and bypass. Fifteen patients had unruptured and six had ruptured aneurysms. The mean follow-up period was 88 months. Six (28%) aneurysms had a small residual neck remnant. Of the 12 patients with documented preoperative visual deficit, 9 (75%) improved, 2 (16%) remained stable, and 1 (8%) worsened. Two patients had mild to moderate new visual deficit. Thus, the surgery-related visual complications were 14%. Eighteen patients (86%) had a good or excellent outcome (GOS IV and V). Presentation with prior visual deficit and poor neurological function were predictors of worse visual and clinical outcome, respectively (P = 0.02 and 0.01).
CONCLUSIONS: There is considerable surgery-related risk for optic pathways during treatment of very large and giant ophthalmic segment aneurysms. Surgery, however, seems to be the treatment of choice in terms of overall visual outcome and aneurysm obliteration as compared to the current endovascular results in this subset of patients.

Entities:  

Mesh:

Year:  2011        PMID: 21947424     DOI: 10.1007/s00701-011-1167-2

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

1.  Incomplete occlusion and visual symptoms of peri-ophthalmic aneurysm after treatment with a pipeline embolization device: a multi-center cohort study.

Authors:  Chao Xu; Pei Wu; Bowen Sun; Shancai Xu; Bin Luo; Xinjian Yang; Huaizhang Shi
Journal:  Acta Neurochir (Wien)       Date:  2022-05-13       Impact factor: 2.816

2.  Resolution of mass effect and compression symptoms following endoluminal flow diversion for the treatment of intracranial aneurysms.

Authors:  I Szikora; M Marosfoi; B Salomváry; Z Berentei; I Gubucz
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-14       Impact factor: 3.825

Review 3.  Factors affecting formation and rupture of intracranial saccular aneurysms.

Authors:  S Bacigaluppi; M Piccinelli; L Antiga; A Veneziani; T Passerini; P Rampini; M Zavanone; P Severi; G Tredici; G Zona; T Krings; E Boccardi; S Penco; M Fontanella
Journal:  Neurosurg Rev       Date:  2013-12-04       Impact factor: 3.042

4.  Treatment Outcomes of Cerebral Aneurysms Presenting with Optic Neuropathy: A Retrospective Case Series.

Authors:  Koji Hirata; Yoshiro Ito; Wataro Tsuruta; Tomoji Takigawa; Aiki Marushima; Masayuki Sato; Mikito Hayakawa; Yasunobu Nakai; Noriyuki Kato; Kazuya Uemura; Kensuke Suzuki; Yuji Matsumaru; Akio Hyodo; Eiichi Ishikawa; Akira Matsumura
Journal:  Asian J Neurosurg       Date:  2019 Apr-Jun

5.  Evidence of Asymptomatic Visual Losses after Surgical Repair of Cerebral Aneurysm.

Authors:  Albedy Moreira Bastos; Anderson Raiol Rodrigues; Maria Izabel Tentes Côrtes; Eliza Maria da Costa Brito Lacerda; Mônica Gomes Lima; Cláudio Eduardo Corrêa Teixeira; Luiz Carlos de Lima Silveira
Journal:  Front Neurol       Date:  2017-09-21       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.